Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 21Head & Neck 9Dermatologic 7Breast 4Lymphoid 3CNS 3Myeloid 2Genitourinary 2Gastrointestinal 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Ovarian Neoplasms 3160Uterine Cervical Neoplasms 2182Endometrial Neoplasms 1330Breast Neoplasms 816Fallopian Tube Neoplasms 807Carcinoma, Ovarian Epithelial 771Neoplasms 540Colorectal Neoplasms 437Carcinoma, Non-Small-Cell Lung 418Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 353Prostatic Neoplasms 317Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 236Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 224Head and Neck Neoplasms 221Sarcoma 218Carcinoma, Renal Cell 213Recurrence 212Colonic Neoplasms 210Papillomavirus Infections 205Triple Negative Breast Neoplasms 189Squamous Cell Carcinoma of Head and Neck 175Vaginal Neoplasms 147

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Soft Tissue Neoplasms × Gynecologic × Clear all
NCT03159585 2020-01-22

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Zhujiang Hospital

Phase 1 Completed
6 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Soft Tissue Neoplasms, Stomach Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡